MAMahmut Aslan

Mahmut Aslan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mahmut Aslan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nöral Tüp Defektleri

    by Mahmut Aslan, Serdal Güngör

    Nöral tüp defektleri, merkezi sinir sistemini etkileyen ciddi doğumsal anomalilerdir ve spina bifida gibi farklı klinik formlarla ortaya çıkarlar. Genetik yatkınlık ile çevresel faktörlerin etkileşimi sonucu gelişimsel bozukluk olarak meydana gelirler. Maternal folik asit takviyesi, gebelik öncesi ve erken dönemde bu defektlerin önlenmesinde hayati bir öneme sahiptir. Tanı ve tedavi süreçleri, multidisipliner tıbbi yaklaşımlar gerektirir. Neural tube defects are significant congenital anomalies affecting the central nervous system, presenting in various clinical forms such as spina bifida. They arise as developmental disorders driven by an interaction between genetic predisposition and environmental factors. Maternal folic acid supplementation during the periconceptional period plays a vital role in the prevention of these conditions. Management and diagnostic processes require a comprehensive, multidisciplinary medical approach.

  • Open Access

    Çocuk Yoğun Bakım Ünitesinde Trakeostomi Uygulamaları, Tek Merkez Deneyimi

    by Merve Havan, Ali Tunç, Murat Ersoy, Mahmut Aslan, Arman Api̇

    Background/Aims: Tracheostomy is one of the most frequently performed surgical procedures in the pediatric intensive care unit (PICU). While it used to be an emergency treatment method in patients with laryngeal obstruction, it is now mostly used in patients with prolonged mechanical ventilation under elective conditions. In this study, we aimed to evaluate patients who underwent tracheostomy in our PICU, indications, and complications. Methods: This retrospective study was conducted from February 2018 through April 2022. Data was collected from the patient’s records and analyzed. Results: Forty-three patients were included in the study. The median age of the patients was 5±4.99 (0-17 years) and 30 patients (69.8%) were male. During the four-year study period, the tracheostomy rate was 2.4% and the decannulation rate was 7%. All of the patients were discharged home with the home ventilator. The most common indication for tracheostomy was prolonged mechanical ventilation (88.3%). The median time of mechanical ventilation before tracheostomy was 111.6±57.22 (range 0-240) days. No surgical complications were observed during the PICU follow-up. All patients were discharged from PICU with a home-type mechanical ventilator. The median number of outpatient controls after discharge was 7.28±1.89 (range 3-10), and the median number of annual cannula replacements was 3.62±0.76 (range 1-5). 14 patients died after discharge from the PICU. None of the patients died due to tracheostomy complications. The median time of death was 30±13.97 (range 11-56) days after discharge from the PICU. When the surviving and deceased patients were compared according to age, mechanical ventilation time, and length of stay in the PICU, no significant difference was found (p=0.291, p=0.115, and p=0.291, respectively). Conclusions: In our study, long mechanical ventilation time was the most common indication for tracheostomy, and our result is consistent with the literature. Although the timing of tracheostomy was long, no significant correlation was observed with mortality.

  • Open Access

    The Importance of Long-Term Video Electroencephalography Monitoring in the Differential Diagnosis of Epilepsy in Children

    by Mahmut Aslan, Serdal Gungor

    Objective: Epilepsy is a condition in which abnormal, recurring, and excessive neuronal discharges caused by many different disorders in the central nervous system are observed. The rate of detecting epileptiform activity in the first interictal electroencephalography (EEG) of patients with epilepsy is around 40%, even when routine activation methods are applied. Video recordings simultaneously with EEG recordings enable the establishment of correlations between abnormalities. Patients and methods: The long-term video-EEG monitoring (VEM) reports and images of 87 patients hospitalized in the video EEG service in the Pediatric Neurology Clinic of İnönü University between 2016 and 2020 were retrospectively analyzed in this study. Demographic information of the patients, such as age, gender, diagnosis/history, and length of hospital stay, was analyzed. Results: A total of 87 patients were included in the study. Of the patients, 54 (62.1%) were male and 33 (37.9%) were female. The mean age was 107.57 ± 64.40 months. While 10 (11.5%) patients followed up with non-epileptic paroxysmal events (NEPE) were taking antiepileptic drugs (AEDs), AED treatments were discontinued after VEM. The diagnosis of 18 (20.69%) patients changed after VEM. The medications of 27 (31%) patients who took AEDs before VEM were discontinued after VEM. During VEM, sleep movement, psychogenic seizures, infantile masturbation, and tic disorder were observed in 19 (41.3%), 17 (36.9%), three (6.5%), and three (6.5%) patients, respectively. Conclusion: In conclusion, VEM is the gold standard diagnostic method used to distinguish between epilepsy and NEPEs. After VEM, the clinical diagnosis of patients can change, and unnecessary drug administration may be prevented. Psychogenic nonepileptic seizures and NEPEs are common in the pediatric population; however, they are often overlooked.


  • A Retrospective Evaluation of Children Diagnosed with Dermatomyositis: A Single-center Study

    by Mahmut Aslan, Serdal Güngör, Yılmaz Tabel, Bilge Özgör, Serkan Kırık

  • Hipotonik İnfant

    by Mahmut Aslan

    Hipotonik infant, süt çocukluğu döneminde kas tonusunun azalmasıyla karakterize, "gevşek bebek" olarak da bilinen bir durumdur. Santral sinir sistemi (%60-80) veya periferik sinir sistemi (%20-40) kaynaklı olabilen bu tablo, bebeklerde baş tutma ve oturma gibi gelişim basamaklarında gecikmelere yol açar. Tanı sürecinde hamilelik öyküsü, aile geçmişi ve fizik muayene kritik rol oynarken; "kurbağa bacağı" duruşu ve traksiyonda başın geriye düşmesi tipik muayene bulgularıdır. Santral nedenler arasında hipoksik iskemik ensefalopati ve Down sendromu gibi genetik bozukluklar öne çıkarken; periferik nedenlerde Spinal Musküler Atrofi (SMA) ve miyastenik sendromlar sıklıkla görülür. Ayırıcı tanıda uyanıklık düzeyi, derin tendon refleksleri ve eşlik eden dismorfik bulgular yol göstericidir. Teşhis aşamasında biyokimya, kreatin kinaz düzeyi, genetik testler, MRG ve EMG gibi tetkiklerden yararlanılır. Tedavi genellikle semptomatik ve destekleyici olup multidisipliner bir yaklaşım gerektirir; ancak SMA için Spinraza ve Pompe hastalığı için enzim replasmanı gibi özel tedavi seçenekleri de mevcuttur. Hypotonic infant is a condition characterized by decreased muscle tone during infancy, also known as "floppy infant," which can originate from the central nervous system (60-80%) or the peripheral nervous system (20-40%) and leads to delays in developmental milestones such as head control and sitting. The diagnostic process relies heavily on pregnancy history, family background, and physical examination, where clinical signs like the "frog-leg" posture and head lag during traction are typical; central causes include hypoxic-ischemic encephalopathy and genetic syndromes like Down syndrome, while peripheral causes often involve Spinal Muscular Atrophy (SMA) and myasthenic syndromes. Differential diagnosis is guided by alertness levels, deep tendon reflexes, and accompanying dysmorphic features, utilizing laboratory tests such as creatine kinase levels, genetic analysis, MRI, and EMG for confirmation. Treatment is generally symptomatic and supportive, requiring a multidisciplinary approach, although specific medical interventions like Spinraza for SMA and enzyme replacement therapy for Pompe disease are available.

  • Güncel Çocuk Sağlığı ve Hastalıkları III

    by Fatih Varol, Aziz Kılıç, Büşra Öz, Cemaliye Başaran, Demet Alaygut, Merthan Tunay, Oğuzhan Kahraman, Yılmaz Akbaş, Mahmut Aslan, Yusuf Deniz, et al.

    Akademisyen Yayınevi yöneticileri, yaklaşık 30 yıllık yayın tecrübesini, kendi tüzel kişiliklerine aktararak uzun zamandan beri, ticarî faaliyetlerini sürdürmektedir. Anılan süre içinde, başta sağlık ve sosyal bilimler, kültürel ve sanatsal konular dahil 2000 kitabı yayımlamanın gururu içindedir. Uluslararası yayınevi olmanın alt yapısını tamamlayan Akademisyen, Türkçe ve yabancı dillerde yayın yapmanın yanında, küresel bir marka yaratmanın peşindedir.Bilimsel ve düşünsel çalışmaların kalıcı belgeleri sayılan kitaplar, bilgi kayıt ortamı olarak yüzlerce yılın tanıklarıdır. Matbaanın icadıyla varoluşunu sağlam temellere oturtan kitabın geleceği, her ne kadar yeni buluşların yörüngesine taşınmış olsa da, daha uzun süre hayatımızda yer edineceği muhakkaktır.

  • Effectiveness of zonisamide in childhood refractory epilepsy

    by Mahmut Aslan, Serdal Gungor

    Introduction Zonisamide (ZNS) is a new generation antiepileptic drug (AED) used in refractory epilepsy. This study assessed the effectiveness and reliability of ZNS in childhood refractory epilepsy. Method Sixty-eight epilepsy patients who were followed up in the paediatric neurology clinic, between 2013 and 2019, and in whom add-on therapy ZNS had been added as their seizures had continued despite multiple drugs being used, were included in this retrospective study. Their demographic findings, seizure aetiology, pre-treatment and post-treatment electroencephalography findings, treatment responses and any side effects of the drugs given were assessed in these patients. Results There were 46 (67.6%) patients in the refractory generalized epilepsy (RGE) group using multiple AEDs and 22 (32.35%) patients in the refractory focal epilepsy (RFE) group. Of these patients, 12 (17.65%) were being followed up for idiopathic epilepsy and 8 (11.76%) were being followed up for epilepsy of unknown aetiology. Twenty-two (32.36%) patients were followed up for structural abnormality, 8 patients (11.77%) were followed up for genetic disease, 4 patients (5.88%) were followed up for infectious sequel, 14 patients (20.59%) were followed up for metabolic reasons. In the RGE group, a more than 50% reduction was found in the seizures of 26 (56.5%) patients, while the seizures of 7 (15.2%) patients were found to have terminated completely. In the RFE group, a more than 50% reduction was found in the seizures of 19 (86.4%) patients, while the seizures of 2 (9.1%) patients were found to have terminated completely. The termination or a more than 50% reduction in seizures in 4 of the 6 patients followed up for a diagnosis of tuberous sclerosis complex (TSC) was significant. Conclusion ZNS is an effective and reliable option as an add-on therapy in paediatric refractory epilepsy, especially in focal epilepsy. It can also be considered for treatment in TSC patients.


  • Open Access

    Evaluation of Patients Presenting With First Febrile Seizure

    by Mahmut Aslan

    Febrile seizure (FS) is the most common cause of convulsion in children. In the present study, we evaluated patients presenting with FS. Eighty-two patients aged between 6-60 months who presented to Mersin City Training and Research Hospital with the first febrile seizure between January 2020 and May 2021 were included in the study. Of the 82 patients included in our study, 42 (51,2%) were male and 40 were female (48,8%). Their average age at presentation of first febrile seizure was 21,05 ± 16,22 months. Fever focus was found in 32 patients (39,1%) with upper respiratory tract infection. Epileptic abnormality was observed in the EEG of six patients (7,3%) and antiepileptic medication was started in three of these patients. Upper respiratory tract infection, family history of FS, and family history of epilepsy are the main risk factors for the development of FS. Complex FS is a serious risk factor for the development of epilepsy.


  • Open Access

    A novel SCN1A mutation: A case report

    by Mahmut Aslan, Bilge Ozgor, Serkan Kirik, Serdal Gungor

    Introduction: Dravet syndrome (DS) is characterized by severe infant-onset myoclonic epilepsy with delayed psychomotor development and increased premature mortality. The seizures triggered by fire have been gradually decreased over time, and finally they start to occur without fever at the age of 2–3 years. Along with its initiation of myoclonic seizures in the early period, other types such as atypical absence, versive, and complex partial seizures occur between 1 and 4 years of age. Case Report: A 3-year-old male patient with refractory epilepsy and neuromotor developmental retardation was admitted to our clinic. The patient initially had seizures in the afebrile period, when he was 4 months old, and he had a total of five seizures by the age of 1 year. Neuromotor developmental retardation developed over time in patients with normal neuromotor development in the early stages of his life. His cranial magnetic resonance imaging and metabolic test findings were normal. The SCN1A mutation was investigated, and a new variant mutation of SCN1A, homozygous (p.Y1599Ffs*19-c.4796delA) was detected. The patient’s family was also screened and this new mutation was detected as heterozygous mutation. The patient had hepatomegaly. The etiology of hepatomegaly was investigated but no cause was found. Conclusion: Variant mutations of DS should be kept in mind and diagnostic genetic testing should be done in patients with neuromotor developmental retardation starting with afebrile seizures. In DS, hepatomegaly is not an expected condition. Maybe this new mutation might have caused hepatomegaly.